MassChallenge Startups Create Impact


Startups Accelerated


Funding Raised


Revenue Generated


Jobs Created

Our startups

Be inspired. Search our startups.

flowbone SA
flowbone SA

In 2010, just in Europe, 27.6 million osteoporotic patients suffered from 610'000 hip fractures whose direct costs were estimated to €19.6 billion. In our ageing population, these numbers are expected to double by 2050. At flowbone, we have developed a new generation of biomaterial that is injected in the bone under local anesthesia, is expected to create 3x more bone in 3x less time than the most potent drug therapies with no side effects and has the potential to make hip fractures history.
The most efficient treatment for osteoporotic hip fracture prevention given as a 1 local injection under local anesthesia every 3-5 years

Connect with flowbone SA


2020 Finalist Switzerland

Sub industry

Medical Devices


Our mission is to equip bold entrepreneurs to disrupt the status quo and to create meaningful change.